Evaluation of Metabolic Changes in Acute Intermittent Porphyria Patients by Targeted Metabolomics.

Gomez-Gomez, Alex; Aguilera, Paula; Langohr, Klaus; Casals, Gregori; Pavon, Cristina; Marcos, Josep; To-Figueras, Jordi; Pozo, Oscar J

Gomez-Gomez, Alex; Aguilera, Paula; Langohr, Klaus; Casals, Gregori; Pavon, Cristina; Marcos, Josep; To-Figueras, Jordi; Pozo, Oscar J.

Affiliation

Gomez-Gomez A; Applied Metabolomics Research Group, IMIM, Hospital del Mar, Doctor Aiguader 88, 08003 Barcelona, Spain.
Aguilera P; Integrative Pharmacology and Systems Neuroscience Group, IMIM, Hospital del Mar, Doctor Aiguader 88, 08003 Barcelona, Spain.
Langohr K; Department of Medicine and Life Sciences (CEXS-UPF), University Pompeu Fabra, Doctor Aiguader 88, 08003 Barcelona, Spain.
Casals G; Diagnosis and Management of Porphyria Clinic, Department of Dermatologyt, Hospital Clinic, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain.
Pavon C; Integrative Pharmacology and Systems Neuroscience Group, IMIM, Hospital del Mar, Doctor Aiguader 88, 08003 Barcelona, Spain.
Marcos J; Department of Statistics and Operations Research, Universitat Politècnica de Barcelona Barcelonatech, 08034 Barcelona, Spain.
To-Figueras J; Biochemistry and Molecular Genetics Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain.
Pozo OJ; Cerba Internacional, Pl. Ramon Llull 7-10, 08203 Sabadell, Spain.

Int J Mol Sci ; 23(6)2022 Mar 16.

Article de En | MEDLINE | ID: mdl-35328641

Sujet(s)
Mots clés

LC-MS/MS; acute intermittent porphyria; kynurenine; metabolomics; tricarboxylic acid cycle; tryptophan

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Porphyrie aigüe intermittente Limites: Humans Langue: En Journal: Int J Mol Sci Année: 2022 Type de document: Article Pays d'affiliation: Espagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google